Cell Therapy Technologies Market Snapshot

“The Cell Therapy Technologies Market is estimated to increase at a CAGR 9.98% from $ 15.63 Billion in 2023 to $ 32.78 Billion by 2030.”

Cell therapy technologies have the potential to revolutionize disease treatment, including autoimmune diseases, cancer, heart problems, and neurological issues. Product development in this market involves continuous research and clinical trials to assess safety and effectiveness of cell-based medicines.

Researchers and businesses are exploring various strategies, including gene treatments, tissue engineering, cell-based immunotherapies, and ex vivo cell multiplication methods. CAR-T cell treatments have made significant progress in cancer treatment.

Stem cell treatments are being explored for neurodegenerative disorders, cardiac ailments, and spinal cord injuries. The goal is to increase the variety of cell therapies while enhancing their efficacy, safety, and accessibility.

Cell-based therapies have the potential to unlock the full potential of these technologies, allowing for precise and targeted interventions tailored to each patient's genetic makeup.

As research and regulatory frameworks continue to grow, the availability and cost-effectiveness of these therapies are expected to increase, paving the way for a new era of healthcare, offering hope for incurable diseases and transforming medical care.

The market for cell therapy is expanding due to increased government funding, rising incidence of infectious and chronic diseases, numerous oncology-related cell therapy clinical trials, and the rise in GMP certifications for cell therapy production facilities.

>>>Download Sample Report Now: https://marketreportservice.com/request-sample/cell-therapy-technologies-market-54671 

Market Trends

Cell therapy, a promising approach in regenerative medicine, relies on advanced technologies for effective cell characterisation, distribution, and production. The cell treatment industry is investing heavily in R&D to improve scalability, safety, and effectiveness of cell therapies.

These technologies cover various fields, including cryopreservation procedures, cell characterisation tools, cell culture systems, and cell isolation & expansion techniques. The focus is on creating sophisticated cell culture systems, which include culture media, growth agents, and bioreactors, to create optimal conditions for cell proliferation.

Growth Drivers

The global cell therapy industry is experiencing growth due to the rise in infections and chronic illnesses, as well as the rise in diabetes cases. With 573 million people affected in 2022, the number is expected to rise to 643 million by 2032 and 783 million by 2045.

The market for cell treatment technologies is also expanding due to research projects and clinical trials. The adoption of innovative technologies is a key driver of this growth.

Cell therapy technologies aid in the diagnosis and prognosis of diseases like HIV/AIDS, cancer, and infectious diseases. They provide researchers and medical practitioners with insights into disease processes, development, and therapy responses.

With increasing human-animal contact, global population growth, and climate change, new virus outbreaks are more likely. Cell therapy research and applications are crucial in addressing these issues by offering advanced diagnostic instruments and therapeutic approaches.

Restraints

Cell biology research aims to develop novel treatments like gene and stem cell therapy, requiring high-quality tools, reagents, and supplies. However, complying with regulations and maintaining quality standards can be costly, making it challenging for institutions and small businesses with limited resources to acquire these expensive research items.

Cell Therapy Technologies Market Segment Analysis

by Product

The global cell therapy technologies market is categorized into four segments: cell processing, preservation, handling, distribution, monitoring, and quality control. In 2022, the cell processing sector dominated the market, largely due to the widespread acceptance of technologically advanced products and tools.

The cell therapy technologies market is divided into four segments: research institutes, biopharmaceutical & biotechnology businesses, CROS & CMOs, and cell banks.

In 2022, the biopharmaceutical & biotechnology firms sector dominated due to factors like growing financing, increased academic activity, and collaboration between biopharma and the industry for cell-therapy product research and development.

The COVID-19 pandemic has boosted the global market for cell therapy technology, with Calidi Biotherapeutics Inc.'s Investigational New Drug application accepted by the FDA for the use of stem cells in COVID-19 diagnosis and treatment. This has led to an expected rise in the market for cell treatment technologies.

Competitive Landscape of the Cell Therapy Technologies Market Analysis

• Thermo Fisher Scientific
• Merck KGaA (Germany)
• Danaher Corporation (US)
• Becton DickinsonmCompany (US)
• Lonza Group (Switzerland)
• Sartorius AG (Germany)

New Developments in Cell Therapy Technologies Market

March 27, 2023, Thermo Fisher Scientific Opens Cell Therapy Facility at University of California, San Francisco, to Accelerate Development of Breakthrough Therapies.

Thermo Fisher Scientific Inc. the world leader in serving science, and the University of California, San Francisco (UCSF), will accelerate advanced cell therapies for difficult to treat conditions, including cancer, rare diseases, and other illnesses, from a newly opened cGMP manufacturing facility adjacent to UCSF Medical Center’s Mission Bay campus.

The partnership between Thermo Fisher and UCSF, first announced in 2022, has the potential to demonstrate that having scientists, clinicians, and patients closer to a manufacturing site may expedite the development of breakthrough treatments. UCSF’s initial focus at the facility will be on treatments for glioblastoma, multiple myeloma, and other cancers using updated approaches to CAR-T and CRISPR technologies. Therapies for other difficult to treat conditions will follow.

August 16, 2022, Merck and Orna Therapeutics Collaborate to Advance Orna’s Next Generation of RNA Technology

Merck known as MSD outside the United States and Canada, and Orna Therapeutics, a biotechnology company pioneering a new investigational class of engineered circular RNA (oRNA) therapies, today announced a collaboration agreement to discover, develop, and commercialize multiple programs, including vaccines and therapeutics in the areas of infectious disease and oncology.

In March 2023, Thermo fisher scientific Inc. entered into collaboration with Arsenal biosciences Inc. The collaboration allows development of manufacturing process for new cancer treatments. This research and process development-focused collaboration has enabled ArsenalBio to develop a robust manufacturing process for their next-generation, programmable autologous T cells for the treatment of cancer.

In March 2023, Danaher entered into partnership with the University of pennsylvania's center for cellular immunotherapies to solve manufacturing difficulties that are affecting the adoption of cell therapies.

In March 2023, Lonza and Vertex have entered a strategic collaboration to facilitate the manufacturing of Vertex's portfolio of investigational stem cell-derived islet cell therapies. As part of the collaboration, Vertex and Lonza will establish a dedicated manufacturing facility specifically for T1D cell therapies.

Regional Analysis of Global Cell Therapy Technologies Industry

The cell therapy technologies market is divided into four regional segments: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America dominated the market in 2022, driven by leading companies and increasing funding for chronic illness research.

The Asia Pacific market is expected to grow at the highest CAGR due to rising cell-based therapy adoption in developing nations and geographic focus by major players. The market is expected to continue expanding in the coming years.   

North America's high chronic illnesses, including cancer, heart disease, and autoimmune diseases, are key targets for cell therapy. The market expansion is facilitated by a large patient population and increased demand for efficient therapies. Europe's focus on cell therapy research and innovation is gaining attention, with reputable academic institutions, research centers, and biotechnology businesses contributing to the creation of innovative cell therapies.

Segments Covered in the Cell Therapy Technologies Market Report

Segment by Product

• Media, Sera, Reagents
• Cell Engineering products
• Cell Culture Vessels
• Cell therapy Equipment
• System & Software
• Other Products

Segment by Cell Type

• T-Cells
• Stem Cells
• Other Cells

By Cell Process

• Cell Processing
• Cell Preservation, Distribution, and Handling
• Process Monitoring and Quality Control

By End User

• Biopharmaceutical & Biotechnology companies
• CRO’s & CMO’s
• Research Institutes & Cell Banks

Market by Region

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Australia
  • Rest of Asia-Pacific
• Rest of the World
• Middle East
• Africa
• Latin America

Frequently Asked Questions

What is the meaning of Cell Therapy Technologies?

Technologies for cell therapy have the potential to completely change how many diseases are treated, including autoimmune diseases, cancer, heart problems, and neurological issues.

What are some applications of Cell Therapy Technologies?

Treating diseases: Cancers, autoimmune diseases, urinary problems, infectious diseases, neurological disorders, Regenerative medicine: Cord blood cell therapies, Hematopoietic and immunologic reconstitution, Tissue regeneration and repair, New drug discovery and testing.

What is the expected growth rate of the Cell Therapy Technologies market over the next 7 years?

The Cell Therapy Technologies Market is estimated to increase at a CAGR 9.98% from $ 15.63 Billion in 2023 to $ 32.78 Billion by 2030.

Who are the major players in the Cell Therapy Technologies market and what is their market share?

Thermo Fisher Scientific (US), Merck KGaA (Germany), Lonza (Switzerland), Sartorius AG (Germany), and Danaher (US), are prominent players operating and dominating in the market.

Who are the top 3 Cell Therapy Technologies Market Key Vendors?

Thermo Fisher Scientific (US), Merck KGaA (Germany), Lonza (Switzerland), are key players in the Cell Therapy Technologies market.

Which geographical areas dominate the worldwide market for Cell Therapy Technologies?

North America region are emerging as the top regional markets for Cell Therapy Technologies solutions.